Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Biotech Startups
>
Beigene
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="anonymous, post: 6280972"]hahahahaha the next big thing? All me-to 2nd or worst to market. Lots of ex- Genentech which will be over matched once they realize its a lot harder to sell drugs that aren't named rituximab, trastuzumab or bevacizumab. Will be hard to get any coverage in the USA, currently questionable financials and out laying a bunch of cash with little to no revenue coming in from drugs being marketed in China. </p><p><br /></p><p>More likely a great short sell opportunity. Look at the numerous companies in this thread- how many were supposed to 'be the next big thing" and how many are completely struggling. Pipeline is garbage and management is questionable at best. Unless you are currently at Genentech with little equity in your brand and will likely get cut I would stay away. Even if you are at Genentech and likely to get cut the severance and much talked about retention bonuses should be enough to more than make up the sign on RSU and little bump in pay from this dog. </p><p><br /></p><p>But I realize many of you aren't that good and don't have options. If that is the case hopefully you know the hiring managers at Beigene! Seattle Genetics will be hiring soon- much better than this place! You've been warned! Can't wait to quote this thread 1 year from now....[/QUOTE]</p><p><br /></p>
[QUOTE="anonymous, post: 6280972"]hahahahaha the next big thing? All me-to 2nd or worst to market. Lots of ex- Genentech which will be over matched once they realize its a lot harder to sell drugs that aren't named rituximab, trastuzumab or bevacizumab. Will be hard to get any coverage in the USA, currently questionable financials and out laying a bunch of cash with little to no revenue coming in from drugs being marketed in China. More likely a great short sell opportunity. Look at the numerous companies in this thread- how many were supposed to 'be the next big thing" and how many are completely struggling. Pipeline is garbage and management is questionable at best. Unless you are currently at Genentech with little equity in your brand and will likely get cut I would stay away. Even if you are at Genentech and likely to get cut the severance and much talked about retention bonuses should be enough to more than make up the sign on RSU and little bump in pay from this dog. But I realize many of you aren't that good and don't have options. If that is the case hopefully you know the hiring managers at Beigene! Seattle Genetics will be hiring soon- much better than this place! You've been warned! Can't wait to quote this thread 1 year from now....[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Biotech Startups
>
Beigene
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Biotech Startups
>
Beigene
>